Back to results
US 12,710,425 B2Granted
Composition for cancer diagnosis
AssigneeAcurasysbio Co., Ltd.
InventorsHyung Keun Lee, Dong Ki Lee, Sung Ill Jang, So Young Kim, A Reum Yeo, Jong Kyoung Kim, Eun-Ju Chang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a composition capable of diagnosing cancer, specifically pancreatic cancer or the like, a diagnostic kit comprising the same, and a method of providing information for diagnosis using the composition. Also, the present disclosure relates to a pharmaceutical composition capable of preventing or treating pancreatic cancer.
Claims1
A method for diagnosing and treating pancreatic cancer, comprising:
- (a) measuring an expression level of interleukin-7 receptor alpha (IL-7RA), or a gene encoding IL-7RA, in peripheral blood mononuclear cells (PBMCs) obtained from a subject suspected of having pancreatic cancer by quantitative PCR to obtain a ΔCt value;
- (b) diagnosing pancreatic cancer based on the ΔCt value being lower than a predetermined cutoff value, wherein the predetermined cutoff value is a ΔCt value obtained from PBMC samples of normal controls;
- and
- (c) treating the diagnosed pancreatic cancer by pancreatic a cancer surgery.
1 more element
Dependencies are inferred from the claim text.